Related Experiment Video
Updated: Jun 4, 2026
11:05
Production and Administration of Therapeutic Mesenchymal Stem/Stromal Cell (MSC) Spheroids Primed in 3-D Cultures Under Xeno-free Conditions
Published on: March 18, 2017
Growth factor-defined culture medium for human mesenchymal stem cells.
Sumiyo Mimura1, Naohiro Kimura, Mitsuhi Hirata
1JCRB Cell Bank, Laboratory of Cell Cultures, Department of Disease Bioresources, National Institute of Biomedical Innovation, Osaka, Japan.
The International Journal of Developmental Biology
|February 10, 2011
Summary
Researchers developed a serum-free medium for human bone marrow-derived mesenchymal stem cells (hMSCs). This new method supports hMSC proliferation and maintains their pluripotency and differentiation potential for therapeutic applications.
Area of Science:
- Stem Cell Biology
- Regenerative Medicine
- Cell Culture Technology
Background:
- Human bone marrow-derived mesenchymal stem cells (hMSCs) are multipotent stem cells with therapeutic potential.
- Current hMSC culture methods often rely on fetal bovine serum (FBS), which can pose safety and standardization concerns.
- Developing serum-free culture conditions is crucial for clinical translation and understanding hMSC biology.
Purpose of the Study:
- To develop a growth factor-defined, serum-free culture medium for hMSCs.
- To evaluate the effects of this medium on hMSC proliferation, pluripotency marker expression, and differentiation potential.
- To provide a safer and more defined culture system for hMSC research and therapy.
Main Methods:
- Culturing hMSCs in a newly developed serum-free medium.
- Assessing cell proliferation using growth factors like TGF-beta1.
- Analyzing the expression of pluripotency markers (SSEA-3, -4, NANOG, OCT3/4, SOX2) and mesenchymal markers (CD105) via flow cytometry.
- Confirming differentiation capacity into osteoblasts and adipocytes.
Main Results:
- The serum-free medium supported hMSC proliferation, with TGF-beta1 enhancing this effect.
- Expanded hMSCs retained expression of key pluripotency markers (SSEA-3, -4, NANOG, OCT3/4, SOX2).
- A subpopulation of cells co-expressed SSEA-3 and the mesenchymal marker CD105, and retained differentiation potential into osteogenic and adipogenic lineages.
Conclusions:
- A defined, serum-free medium effectively supports the culture of hMSCs.
- This system maintains hMSC pluripotency and differentiation capabilities, crucial for therapeutic use.
- The developed medium is a valuable tool for studying hMSC biology and advancing stem cell-based therapies.
